“This is a result that shows that dexamethasone is life-saving when patients with COVID-19, the be device to a ventilator or oxygen-treated, dexamethasone is administered, and at remarkably low costs,” said Martin Landray, a Professor at the University of Oxford, directs the study.
The results, described by the scientists in the UK led clinical study RECOVERY as a “major breakthrough”, suggest that the drug in patients treated in the hospital with the pandemic illness, immediately to the standard treatment should be, the researchers said.
LONDON, 16. In June, The administration of low doses of the generic Steroid drug dexamethasone to patients who were admitted with COVID-19 to the hospital, reduced the mortality rate in the patients with the most severe infection cases, by about a third, as the study data showed on Tuesday.
Currently there are no approved treatments or vaccines for COVID-19, the disease, which is caused by the new Coronavirus, and the world more than 431.000 people killed. (Reporting by Kate Kelland and Alistair Smout, published by Timothy Heritage)
“It is a great breakthrough,” he said.
His Co-boss, Peter Horby, said that dexamethasone, a generic Steroid that is widely used in other diseases far, in order to reduce inflammation – “is the only drug for the has been shown that it lowers mortality rate and it reduces it significantly”.
Do me a Favor: Please SHARE this post.
Please share this post
–
